Description

6-Bromo-Imidazo[1,2-A]Pyridine-2-Carboxylic Acid Ethyl Ester Hydrobromide is a high-purity, advanced pharmaceutical intermediate with a defined molecular structure. This compound is of significant commercial value for its role as a key building block in the synthesis of complex bioactive molecules. It is primarily required by research institutions and pharmaceutical companies engaged in the development of new therapeutic agents, particularly within medicinal chemistry and process R&D.

Application

• Pharmaceutical Intermediate: A critical precursor in the multi-step synthesis of novel drug candidates, especially those targeting central nervous system (CNS) disorders and other therapeutic areas.
• Medicinal Chemistry Research: Used extensively in lead optimization and structure-activity relationship (SAR) studies to develop new chemical entities with improved efficacy and safety profiles.
• Process Chemistry Development: Serves as a standardized starting material for scaling up synthetic routes from laboratory to pilot plant and commercial manufacturing scales.
• Active Pharmaceutical Ingredient (API) Synthesis: Incorporated into the synthetic pathway of potential Active Pharmaceutical Ingredients (APIs), where its bromo and ester functionalities allow for further chemical modifications.
• Chemical Biology Probes: Utilized in the creation of specialized molecular probes for studying biological pathways and target validation in drug discovery.

Basic Information

Item	Details
Product Name	6-Bromo-Imidazo[1,2-A]Pyridine-2-Carboxylic Acid Ethyl Ester Hydrobromide
CAS No.	1177092-98-6
Molecular Formula	C10H10BrN2O2 • HBr
Molecular Weight	348.02 g/mol
Synonyms	Ethyl 6-Bromoimidazo[1,2-a]pyridine-2-carboxylate Hydrobromide; 6-Bromoimidazo[1,2-a]pyridine-2-carboxylic Acid Ethyl Ester HBr Salt; 6-Bromo-Imidazo[1,2-a]pyridine-2-carboxylic Acid Ethyl Ester Hydrobromide Salt; 1177092-98-6; Ethyl 6-bromoimidazo[1,2-a]pyridine-2-carboxylate hydrobromide salt
EINECS	Contact for details

Quality Control

Our production of 6-Bromo-Imidazo[1,2-A]Pyridine-2-Carboxylic Acid Ethyl Ester Hydrobromide adheres to stringent quality management protocols to ensure batch-to-batch consistency and high purity, essential for sensitive pharmaceutical R&D. Each lot is fully characterized using advanced analytical techniques, including HPLC, NMR, and mass spectrometry. A comprehensive Certificate of Analysis (COA) detailing purity, identity, and impurity profiles is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (typically 15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed under inert atmosphere (e.g., nitrogen or argon) after opening to prevent degradation from moisture absorption.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (HPLC)	Conforms to reference standard
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.